U.S. Poliovirus Containment Survey

At a glance

The U.S. NAC is responsible for ensuring containment requirements are effectively implemented and maintained in facilities retaining poliovirus materials. This survey is designed to collect relevant facility inventory data to ensure compliance with requirements with national containment requirements.

U.S. NAC U.S. National Authority or Containment of Poliovirus logo

Take the Survey

If you received an email directly from the U.S. NAC inviting you to participate in the National Inventory for Poliovirus Containment, please access the survey by clicking on the link provided at the bottom of the email.

If you no longer have the email or if you have any questions about the survey, contact the U.S. NAC.

Survey Overview

The U.S. National Authority for Containment of Poliovirus (U.S. NAC), located in the Centers for Disease Control and Prevention (ÐÇ¿ÕÓéÀÖ¹ÙÍø), Office of Readiness and Response (ORR) appreciates your participation in U.S. Poliovirus Containment Survey. This survey is designed to collect relevant facility inventory data to ensure compliance with requirements with managing and storing poliovirus materials. Maintaining a national inventory of poliovirus-containing materials helps protect the United States.

Audience

The survey should be completed by facilities that test, extract, handle, or store poliovirus or biological samples from humans, experimentally infected animals, sewage, or environmental waters including:

  • Laboratories
  • Storage sites
  • Wastewater facilities

Purpose: identify infectious poliovirus and PIM

Unlike previous releases of the national survey that focused on identifying facilities with infectious poliovirus, this release puts greater emphasis on poliovirus potentially infectious materials (PIM) in addition to infectious poliovirus. PIM should be identified based on where and when the specimens were collected, not based on any test results.

PIM includes human fecal samples and upper respiratory secretions collected for polio or non-polio related work in a time and place where one of the following apply:

  1. Wild poliovirus (WPV) was circulating
  2. Vaccine-derived poliovirus (VDPV) was circulating
  3. Oral polio vaccine (OPV) was in use

Historical domestic and international specimens are more likely to fall into the categories above. Also, PIM cultured in some common cell lines to isolate other viruses of interest may unintentionally amplify poliovirus. Respiratory or enteric viral isolates obtained from PIM specimens using poliovirus-permissive cell lines are also considered PIM. For more details, see Appendix C Common Cell Lines and Animals Susceptible to Poliovirus.

If you need assistance, contact the U.S. NAC.

After identifying infectious poliovirus or PIM

Facilities are encouraged to destroy all unneeded or nonessential poliovirus material. If your facility intends to destroy some or all the poliovirus PIM or infectious material it possesses, please contact the U.S. NAC to complete an attestation of destruction for the material.

Survey Guidance

The U.S. National Survey Guidance for Poliovirus Containment is intended to help you prepare your survey responses prior to completing the survey online. Note, the survey cannot be submitted in a paper-based format. This guidance includes instructions, appendices, definitions, and other references.

The survey is divided into six modules:

  1. Facility Information
  2. Material Types
  3. Inventory Information
  4. Disposition of Materials
  5. Key Facility Personnel
  6. Attestation

In the survey, you will be asked to state the scope of your responses (i.e., if you represent a single laboratory, department, or entire institution). This is important and helps us to determine if your facility is adequately represented. The amount of time needed to complete the survey will vary depending on the complexity of your laboratory or facility and the availability of needed information.

Please contact the U.S NAC if you have any questions about the survey.

Appendices

Content Source: